Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Two bioinformatics experts have used AI to accurately estimate regional COVID infection rates, aka seroprevalence, in all 50 states and 50 hard-hit countries.
The plan is to draw health data from every available source to continuously nudge individuals toward not only appropriate medical care but also healthier lifestyles.
AI has proven capable of automatically detecting looming heart trouble on CT scans taken for lung issues like lung cancer, pulmonary embolism and pneumonia.